Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Mar;48(3):1024-7.
doi: 10.1128/AAC.48.3.1024-1027.2004.

Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II

Affiliations

Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II

Isabelle Verdier et al. Antimicrob Agents Chemother. 2004 Mar.

Abstract

We used multiplex PCR to determine the agr group membership of 18 European glycopeptide heterointermediate and intermediate-resistant Staphylococcus aureus strains. Of the 15 agr group I strains, 13 were resistant and 2 were susceptible to methicillin. The remaining three strains, like the United States and Japanese control strains, belonged to agr group II.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
PFGE patterns and phylogenetic tree of 22 GISA and hGISA isolates and 35 non-GISA and non-hGISA S. aureus isolates from the United States, Japan, and Europe. Isolate designations in boldface characters indicate the GISA-hGISA phenotype. SmaI macrorestriction patterns were digitized and analyzed with Taxotron software (Institut Pasteur, Paris, France) to calculate Dice coefficients of correlation and to generate a dendrogram by the unweighted pair group method using arithmetic averages (unweighted pair group method with arithmetic mean) clustering. The scale indicates the levels of pattern similarity. The fragment size (in kilobases) of reference strain NCTC8325 is indicated on the bottom lane.

References

    1. Bierbaum, G., K. Fuchs, W. Lenz, C. Szekat, and H. G. Sahl. 1999. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur. J. Clin. Microbiol. Infect. Dis. 18:691-696. - PubMed
    1. Bobin-Dubreux, S., M. E. Reverdy, C. Nervi, M. Rougier, A. Bolmstrom, F. Vandenesch, and J. Etienne. 2001. Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative. Antimicrob. Agents Chemother. 45:349-352. - PMC - PubMed
    1. Centers for Disease Control and Prevention. 2000. Staphylococcus aureus with reduced susceptibility to vancomycin—Illinois, 1999. Morb. Mortal. Wkly. Rep. 48:1165-1167. - PubMed
    1. Centers for Disease Control and Prevention. 1997. Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997. Morb. Mortal. Wkly. Rep. 46:765-766. - PubMed
    1. Chang, S., D. M. Sievert, J. C. Hageman, M. L. Boulton, F. C. Tenover, F. P. Downes, S. Shah, J. T. Rudrik, G. R. Pupp, W. J. Brown, D. Cardo, and S. K. Fridkin. 2003. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 348:1342-1347. - PubMed

MeSH terms